当前位置：药药网 / 药品 / 美国NDC复合药物数据库文件(本栏目更新到2026-3-31)
药品名称： 商品名称： 药品NDC： 报告期内： -格式:2020-5-3
NDC包装id： 市场分类： 活性成分： 持证企业：
 美国NDC复合药物数据库文件4843条(本栏目更新到2026-3-31)
药品名称(分析)
商品名
药品NDC
专利人(分析)
报告期内
活性成分
市场分类
规格(分析)
NDC包装id
Phenylephrine Hydrochloride
HUMAN COMPOUNDED DRUG
71506-026
Fresenius Kabi Compounding LLC DBA Fagron Sterile Services
2024-1
PHENYLEPHRINE HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
400 ug/5 mL
71506-026-51
Rocuronium Bromide
HUMAN COMPOUNDED DRUG
71506-099
Fresenius Kabi Compounding LLC DBA Fagron Sterile Services
2024-1
ROCURONIUM BROMIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
50 mg/5 mL
71506-099-05
Lidocaine Hydrochloride
HUMAN COMPOUNDED DRUG
71506-041
Fresenius Kabi Compounding LLC DBA Fagron Sterile Services
2024-1
LIDOCAINE HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
100 mg/5 mL
71506-041-05
Norepinephrine Bitartrate
HUMAN COMPOUNDED DRUG
71506-027
Fresenius Kabi Compounding LLC DBA Fagron Sterile Services
2024-1
NOREPINEPHRINE BITARTRATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
8 mg/250 mL
71506-027-58
Oxytocin
HUMAN COMPOUNDED DRUG
71506-028
Fresenius Kabi Compounding LLC DBA Fagron Sterile Services
2024-1
OXYTOCIN
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
30 U/500 mL
71506-028-59
Phenylephrine Hydrochloride
HUMAN COMPOUNDED DRUG
71506-008
Fresenius Kabi Compounding LLC DBA Fagron Sterile Services
2024-1
PHENYLEPHRINE HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
80 mg/250 mL
71506-008-58
B-Complex
HUMAN COMPOUNDED DRUG
70657-1019
MedisourceRx
2024-1
NIACINAMIDE; PYRIDOXINE; THIAMINE HYDROCHLORIDE; RIBOFLAVIN 5'-PHOSPHATE SODIUM
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
100 mg/1 mL; 2 mg/1 mL; 100 mg/1 mL; 5 mg/1 mL
70657-1019-3
L-Methionine, Inositol
HUMAN COMPOUNDED DRUG
70657-1026
MedisourceRx
2024-1
INOSITOL; METHIONINE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
50 mg/1 mL; 25 mg/1 mL
70657-1026-3
Methylcobalamin
HUMAN COMPOUNDED DRUG
70657-1223
MedisourceRx
2024-1
METHYLCOBALAMIN
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
5 mg/1 mL
70657-1223-3
Glutathione (reduced)
HUMAN COMPOUNDED DRUG
70657-1014
MedisourceRx
2024-1
GLUTATHIONE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
200 mg/1 mL
70657-1014-3
Semaglutide
HUMAN COMPOUNDED DRUG
70657-1027
MedisourceRx
2024-1
SEMAGLUTIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
2.5 mg/1 mL
70657-1027-5
Ketamine
HUMAN COMPOUNDED DRUG
71266-9081
Fagron Compounding Services LLC dba Fagron Sterile Services LLC dba JCB Laboratories
2024-1
KETAMINE HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
10 mg/1 mL
71266-9081-1
Norepinephrine Bitartrate
HUMAN COMPOUNDED DRUG
71266-5025
Fagron Compounding Services LLC dba Fagron Sterile Services LLC dba JCB Laboratories
2024-1
NOREPINEPHRINE BITARTRATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
64 ug/1 mL
71266-5025-2
Oxytocin
HUMAN COMPOUNDED DRUG
71266-5000
Fagron Compounding Services LLC dba Fagron Sterile Services LLC dba JCB Laboratories
2024-1
OXYTOCIN
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
30 [iU]/500 mL
71266-5000-1
Oxytocin
HUMAN COMPOUNDED DRUG
71266-5100
Fagron Compounding Services LLC dba Fagron Sterile Services LLC dba JCB Laboratories
2024-1
OXYTOCIN
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
30 [iU]/500 mL
71266-5100-1
Tropicamide 1%, Phenylephrine 2.5%
HUMAN COMPOUNDED DRUG
71266-8310
Fagron Compounding Services LLC dba Fagron Sterile Services LLC dba JCB Laboratories
2024-1
PHENYLEPHRINE HYDROCHLORIDE; TROPICAMIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
25 mg/1 mL; 10 mg/1 mL
71266-8310-1
Tropicamide 1%, Cyclopentolate 1%, Phenylephrine 2.5%
HUMAN COMPOUNDED DRUG
71266-8211
Fagron Compounding Services LLC dba Fagron Sterile Services LLC dba JCB Laboratories
2024-1
PHENYLEPHRINE HYDROCHLORIDE; CYCLOPENTOLATE HYDROCHLORIDE; TROPICAMIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
25 mg/1 mL; 10 mg/1 mL; 10 mg/1 mL
71266-8211-1
Tirzepatide
HUMAN COMPOUNDED DRUG
81375-620
PQ Pharmacy LLC
2024-1
TIRZEPATIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
20 mg/1 mL
81375-620-03
Lidocaine 1.0%/ Phenylephrine 1.5% Sterile Injection
HUMAN COMPOUNDED DRUG
81375-515
PQ Pharmacy LLC
2024-1
PHENYLEPHRINE HYDROCHLORIDE; LIDOCAINE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
15 mg/1 mL; 10 mg/1 mL
81375-515-01
Estradiol
HUMAN COMPOUNDED DRUG
70168-2020
BSO, LLC
2024-1
ESTRADIOL
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
10 mg
70168-2020-1
网站地图 - 网站开发 - 网站简介 - 会员服务 - 法律声明 - 联系我们 - 药品招商频道 - 药品信息排行 - 2018年版国家基本药物目录 - 意见反馈
免责声明：以上所展示的信息由企业自行提供，内容的真实性、准确性和合法性由发布企业负责，医药网对此不承担任何责任。
相关链接：医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究　　客服热线：0575-83552251 / 13754370441  QQ客服：药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证：浙B2-20220931　互联网药品信息服务资格证书编号：(浙)-经营性2023-0215　浙公网安备:330683240604819103159
　医药代理商群１：药药网药品采购交流医药代理商群２：药药网药品采购交流2医药代理商群３：药药网药品采购交流3